Drug Patents owned by Viatris
1. List of Neurontin drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7256216 | VIATRIS | Liquid pharmaceutical compositions |
May, 2022
(8 months ago) | |
|
US7256216
(Pediatric) | VIATRIS | Liquid pharmaceutical compositions |
Nov, 2022
(2 months ago) | |
Drugs and Companies using GABAPENTIN ingredient
Market Authorisation Date: 02 March, 2000
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of NEURONTIN before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic